Luiz Euribel Prestes Carneiro
Pneumococcal infection (PI) is one of the most important causes of recurrent respiratory infections. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has been demonstrated cost-effective in reducing the burden of PI. Following immunization with a single dose of PPV23, we track the clinical and serological reaction of individuals diagnosed with recurrent respiratory tract infections.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి